BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3790194)

  • 21. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B; Riek M; Holmes B; Grange S
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phentolamine bioequivalence study.
    Silva LF; Moraes MO; Santana GS; Frota Bezerra FA; De Nucci G; Moraes ME
    Int J Clin Pharmacol Ther; 2004 Jan; 42(1):43-9. PubMed ID: 14756387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.
    Mignini F; Tomassoni D; Streccioni V; Traini E; Amenta F
    Clin Exp Hypertens; 2008 Feb; 30(2):95-108. PubMed ID: 18293165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological availability of gastric juice-resistant coated diclofenac preparations. 1. Bioavailability study following a single administration of a multiple-unit formulation in comparison with a single-unit formulation].
    Scheidel B; Blume H; Walter K; von Nieciecki A; Babej-Dölle RM
    Arzneimittelforschung; 1993 Nov; 43(11):1211-5. PubMed ID: 8292067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics and bioequivalence of two peroral beclobrate preparations].
    Gikalov I; Ifflaender U
    Arzneimittelforschung; 1987 Sep; 37(9):1065-8. PubMed ID: 3435603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new trifluorinated quinolone: Ro 23-6240 (AM 833).
    Weidekamm E; Stöckel K; Dell D
    Drugs Exp Clin Res; 1987; 13(2):85-90. PubMed ID: 3107959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The bioavailability of midodrin and alpha-2,5-dimethoxyphenyl-beta-aminoethanol hydrochloride].
    Grobecker H; Kees F; Linden M; Schrader E; Welte S
    Arzneimittelforschung; 1987 Apr; 37(4):447-50. PubMed ID: 2440455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of pyrimethamine in healthy young volunteers using a new solid phase extraction/HPLC method.
    Le Liboux A; Duquesne H; Montay G; Chassard D; Pichard E; Thebault JJ; Frydman A; Gaillot J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():284-90. PubMed ID: 1820893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of new formulations of amoxicillin in relation to its absorption kinetics.
    Hespe W; Verschoor JS; Olthoff M
    Arzneimittelforschung; 1987 Mar; 37(3):372-5. PubMed ID: 3593455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bioavailability of a controlled-release suspension of phenylpropanolamine in healthy volunteers].
    Chen QC; Chen WL; Dai YQ; Ge GQ; Lin DC
    Yao Xue Xue Bao; 1992; 27(4):299-302. PubMed ID: 1442046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.
    Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the bioequivalence of two ranitidine formulations.
    Hilgenstock C; Schmiedel G; Bührens KG
    Arzneimittelforschung; 1987 Aug; 37(8):974-6. PubMed ID: 3675698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability from various galenic formulations of flunitrazepam.
    Cano JP; Soliva M; Hartmann D; Ziegler WH; Amrein R
    Arzneimittelforschung; 1977; 27(12):2383-8. PubMed ID: 23801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative approach to relative bioavailability and bioequivalence evaluation, with drugs following Michaelis-Menten elimination kinetics.
    Fagiolino P; Stareczek S
    Farmaco; 1990 Sep; 45(9):1027-36. PubMed ID: 2282123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative absorption kinetics of imidazole and salicylic acid in volunteers after administration of ITF 182 tablets and suppositories.
    Noseda G; Fragiacomo C; Peruzzi M; Cremonesi P; Chinea B
    Int J Clin Pharmacol Res; 1988; 8(3):169-73. PubMed ID: 3403104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic analysis of a new acenocoumarol tablet formulation during a bioequivalence study.
    Popović J; Mikov M; Jakovljević V
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):85-9. PubMed ID: 8001599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.
    Rochdi M; Sabouraud A; Girre C; Venet R; Scherrmann JM
    Eur J Clin Pharmacol; 1994; 46(4):351-4. PubMed ID: 7957521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.